Financials
- Market Capitalization 3.14 M
- Employee 2
- Founded 2013
- CEO N/A
- Website www.matinasbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG005WX2XG8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.29
売上高対価格比率
86.7
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 5046 | GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares | 0.54 USD | -3.57% | -5.26% | -15.62% | -73.91% | 3.55 M USD | ||
| 5059 | CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.85 USD | -5.56% | -24.11% | -61.36% | -67.92% | 3.14 M USD | ||
| 5072 | GRI GRI Bio, Inc. - Common Stock | 1.62 USD | -6.90% | -10.99% | -28.32% | -38.87% | 2.87 M USD | ||
| 5076 | XRTX XORTX Therapeutics Inc. - Common Shares | 2.03 USD | -6.88% | -2.40% | -15.42% | +128.09% | 2.83 M USD |